Pilot phase II study with docetaxel in combination with curcuminoids in patients with hormone-resistant prostate cancer (HRPC).

Hakim Mahammedi,E. Planchat,H. Cure,Chantal Barthomeuf,Mathilde Bayet-Robert,M. Mouret-Reynier,Catherine Abrial,Emilie Thivat,Marc Atger,Laurent Savareux,L. Guy,J. Goyard,P. Chollet,Jean-Marc Nabholtz,Xavier Durando,Jean-Christophe Eymard

Pilot phase II study with docetaxel in combination with curcuminoids in patients with hormone-resistant prostate cancer (HRPC).

2011

Hakim Mahammedi
E. Planchat
H. Cure
Chantal Barthomeuf
Mathilde Bayet-Robert
M. Mouret-Reynier
Catherine Abrial
Emilie Thivat
Marc Atger
Laurent Savareux
L. Guy
J. Goyard
P. Chollet
Jean-Marc Nabholtz
Xavier Durando
Jean-Christophe Eymard

e15069 Background: Prostate cancer is the most frequent tumor in men from developed countries. A previous phase I study showed the feasability of curcuminoids in association with docetaxel for adva...

Keywords:

Phases of clinical research
Hormone-Resistant Prostate Cancer
Medicine
Oncology
Internal medicine
Docetaxel
Prostate cancer
pilot phase
phase i study
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations